Considering our findings in this context, it becomes clear that LKB1 loss manifests in substantial modification to the chromatin landscape as evidenced by the availability of the normally repressed CDKN1C promoter and the high expression of CPS1 which is not observed in lung cancers without LKB1 mutations. This evidence concerns the gene STK11 and lung cancer.